Only a clinical trial supply chain partner that exhibits global regulatory and trade compliance proficiency and transports shipments in a secure, compliant, closed-loop environment can successfully address the complex demands of the patient-centric supply chain.

Marken’s Vice President, Clinical Distribution, Cell and Gene Therapy Supply Chain, Nina Vas, evaluates what is needed to develop a patient-centric supply chain in this article.

You can rely on us to provide patient-centric supply chain advantages because we are a wholly owned subsidiary of UPS and the essential clinical part of UPS Healthcare. With Marken, BOMI Group, and Polar Speed included, the UPS Healthcare network staffs 199 locations with 10,000+ employees worldwide.